ERJ
HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH
 QUICK SEARCH:   [advanced]


     


Published online before print September 17, 2008
Eur Respir J 2008, doi:10.1183/09031936.00142407
This Article
Right arrow Full Text (Rapid PDF)
Right arrow Alert me when this article is cited
Right arrow Alert me if a correction is posted
Services
Right arrow Email this article to a friend
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Google Scholar
Right arrow Articles by Sun, J.
Right arrow Articles by Bai, C.
PubMed
Right arrow PubMed Citation
Right arrow Articles by Sun, J.
Right arrow Articles by Bai, C.


ORIGINAL ARTICLE

Effects of curcumin or dexamethasone on lung ischemia-reperfusion injury in rats

J. Sun 1, D. Yang 1, S. Li 1, Z. Xu 2, X. Wang 1, C. Bai 1

1 Dept of Pulmonary Medicine, Zhongshan Hospital, Fudan University, 180 Feng Lin Road, Shanghai, 200032, PR China
2 Dept of Pathology, Fudan University, Shanghai, 200032, PR China


   Abstract

The present study aims at investigating potential effects of curcumin (CUR) and dexamethasone (DXM) on ischemia-reperfusion (IR) induced lung injury in rats.

Experimental rats were pretreated with a single intraperitoneal dose of vehicle, CUR (50mg·kg-1 or 200mg·kg-1) or DXM (5mg·kg-1) 2 h before anaesthesia and subjected to left lung hilus clamping with 90 min ischemia followed by 4 h of reperfusion.

Pretreatment with CUR (200 mg·kg-1) or DXM markedly attenuated IR-induced barrier disruption, lung oedema, tissue inflammation, hypoxemia at 4 h after reperfusion, and oveactivation of NF-{kappa}B, inflammatory cytokines, MPO and malondialdehyde.

It seems that CUR attenuates acute lung injury probably through improving oxidative stress and inhibiting NF-{kappa}B-mediated expression of inflammatory cytokines. Thus, CUR may be an alternative therapy for improving the outcomes of IR induced lung injury.

Keywords:  Curcumin, ischemia-reperfusion (IR), lung, microvascular permeability, NF-{kappa}B, oxidative stress







HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH
Copyright © 2008 by the European Respiratory Society.